Stifel Financial’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-690
| Closed | -$369K | – | 2937 |
|
|
2019
Q2 | $369K | Buy |
690
+12
| +2% | +$6.42K | ﹤0.01% | 2374 |
|
|
2019
Q1 | $341K | Buy |
678
+163
| +32% | +$82K | ﹤0.01% | 2286 |
|
|
2018
Q4 | $253K | Sell |
515
-396
| -43% | -$195K | ﹤0.01% | 2325 |
|
|
2018
Q3 | $833K | Sell |
911
-9
| -1% | -$8.23K | ﹤0.01% | 1795 |
|
|
2018
Q2 | $674K | Sell |
920
-156
| -14% | -$114K | ﹤0.01% | 1864 |
|
|
2018
Q1 | $1.72M | Sell |
1,076
-635
| -37% | -$1.01M | 0.01% | 1244 |
|
|
2017
Q4 | $1.53M | Sell |
1,711
-66
| -4% | -$59.2K | ﹤0.01% | 1286 |
|
|
2017
Q3 | $640K | Sell |
1,777
-3
| -0.2% | -$1.08K | ﹤0.01% | 1741 |
|
|
2017
Q2 | $523K | Sell |
1,780
-161
| -8% | -$47.3K | ﹤0.01% | 1844 |
|
|
2017
Q1 | $684K | Buy |
1,941
+209
| +12% | +$73.7K | ﹤0.01% | 1642 |
|
|
2016
Q4 | $319K | Buy |
+1,732
| New | +$319K | ﹤0.01% | 2009 |
|
|
2016
Q1 | – | Sell |
-797
| Closed | -$201K | – | 2335 |
|
|
2015
Q4 | $201K | Buy |
+797
| New | +$201K | ﹤0.01% | 2113 |
|
|
2015
Q3 | – | Sell |
-1,100
| Closed | -$207K | – | 2326 |
|
|
2015
Q2 | $207K | Sell |
1,100
-80
| -7% | -$15.1K | ﹤0.01% | 2152 |
|
|
2015
Q1 | $194K | Hold |
1,180
| – | – | ﹤0.01% | 2125 |
|
|
2014
Q4 | $274K | Buy |
1,180
+360
| +44% | +$83.6K | ﹤0.01% | 1919 |
|
|
2014
Q3 | $148K | Sell |
820
-8
| -1% | -$1.44K | ﹤0.01% | 2059 |
|
|
2014
Q2 | $160K | Buy |
828
+7
| +0.9% | +$1.35K | ﹤0.01% | 2038 |
|
|
2014
Q1 | $150K | Buy |
+821
| New | +$150K | ﹤0.01% | 1958 |
|